BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Munoz-Garrido P, Fernandez-Barrena MG, Hijona E, Carracedo M, Marín JJG, Bujanda L, Banales JM. MicroRNAs in biliary diseases. World J Gastroenterol 2012; 18(43): 6189-6196 [PMID: 23180938 DOI: 10.3748/wjg.v18.i43.6189]
URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6189.htm
Number Citing Articles
1
Zhenhua Luo, Anil G. Jegga, Jorge A. Bezerra. Gene‐disease associations identify a connectome with shared molecular pathways in human cholangiopathiesHepatology 2018; 67(2): 676 doi: 10.1002/hep.29504
2
Torsten Voigtländer, Shashi K. Gupta, Sabrina Thum, Jasmin Fendrich, Michael P. Manns, Tim O. Lankisch, Thomas Thum, Wing-Kin Syn. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or CholangiocarcinomaPLOS ONE 2015; 10(10): e0139305 doi: 10.1371/journal.pone.0139305
3
Jose J.G. Marin, Luis Bujanda, Jesus M. Banales. MicroRNAs and cholestatic liver diseasesCurrent Opinion in Gastroenterology 2014; 30(3): 303 doi: 10.1097/MOG.0000000000000051
4
K-Y Lin, H Ye, B-W Han, W-T Wang, P-P Wei, B He, X-J Li, Y-Q Chen. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinomaOncogene 2016; 35(26): 3376 doi: 10.1038/onc.2015.396
5
Aitor Esparza-Baquer, Ibone Labiano, Luis Bujanda, María J. Perugorria, Jesús M. Banales. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic toolsClinics and Research in Hepatology and Gastroenterology 2016; 40(1): 15 doi: 10.1016/j.clinre.2015.10.001
6
Keisaku Sato, Shannon Glaser, Heather Francis, Gianfranco Alpini. Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in CholangiopathiesFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00048
7
Steven P. O’Hara, Sergio A. Gradilone, Tetyana V. Masyuk, James H. Tabibian, Nicholas F. LaRusso. MicroRNAs in CholangiopathiesCurrent Pathobiology Reports 2014; 2(3): 133 doi: 10.1007/s40139-014-0048-9
8
P. Olaizola, P.Y. Lee-Law, A. Arbelaiz, A. Lapitz, M.J. Perugorria, L. Bujanda, J.M. Banales. MicroRNAs and extracellular vesicles in cholangiopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1293 doi: 10.1016/j.bbadis.2017.06.026
9
Irene K. Yan, Valentin X. Berdah, Tushar Patel. Extracellular RNAMethods in Molecular Biology 2018; 1740: 59 doi: 10.1007/978-1-4939-7652-2_6
10
Thijs R. M. Barten, Lucas H. P. Bernts, Joost P. H. Drenth, Tom J. G. Gevers. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney diseaseExpert Opinion on Therapeutic Targets 2020; 24(6): 589 doi: 10.1080/14728222.2020.1751818
11
Yemiao Chen, Catherine M. Verfaillie. MicroRNAs: the fine modulators of liver development and functionLiver International 2014; 34(7): 976 doi: 10.1111/liv.12496
12
M. Cahová, H. Daňková, M. Heczková, M. Brátová, N. Ďásková, H. Baštová, J. Gojda, P. Wohl. MicroRNAs as potential markers of parenteral nutrition associated liver disease in adult patientsPhysiological Research 2019; : 681 doi: 10.33549/physiolres.934103
13
Anne-Margarethe Enge, Heike Sprenger, Albert Braeuning, Stefanie Hessel-Pras. Identification of microRNAs Implicated in Modulating Senecionine-Induced Liver Toxicity in HepaRG CellsFoods 2022; 11(4): 532 doi: 10.3390/foods11040532
14
Youwen Tan, Tengli Pan, Yun Ye, Guohong Ge, Li Chen, Danfeng Wen, Shengqiang Zou, Aftab A. Ansari. Serum MicroRNAs as Potential Biomarkers of Primary Biliary CirrhosisPLoS ONE 2014; 9(10): e111424 doi: 10.1371/journal.pone.0111424
15
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Journal of Clinical Medicine 2015; 4(12): 2028 doi: 10.3390/jcm4121958
16
Douglas V.N.P. Oliveira, Shanshan Zhang, Xin Chen, Diego F. Calvisi, Jesper B. Andersen. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targetsExpert Review of Gastroenterology & Hepatology 2017; 11(4): 349 doi: 10.1080/17474124.2017.1292127
17
Maria Pisarello, Lorena Loarca, Tommy Ivanics, Leslie Morton, Nicholas LaRusso. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentJournal of Clinical Medicine 2015; 4(9): 1688 doi: 10.3390/jcm4091688
18
Céline Demarez, Catherine Hubert, Christine Sempoux, Frédéric P. Lemaigre, Heather Francis. Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic CholangiocarcinomaPLOS ONE 2016; 11(6): e0157140 doi: 10.1371/journal.pone.0157140
19
A.E. Abaturov, V.L. Babуch. The role of miRNAs in the development of cholangiopathies. Part 1CHILD`S HEALTH 2023; 18(4): 323 doi: 10.22141/2224-0551.18.4.2023.1606
20
Zheng Fang, Lei Lu, Zhiqiang Tian, Kunlun Luo. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinomaMedical Oncology 2014; 31(5) doi: 10.1007/s12032-014-0940-5
21
Ning Wang, Shihai Xia, Kai Chen, Xiaohui Xiang, Aijun Zhu. Genetic alteration regulated by microRNAs in biliary tract cancersCritical Reviews in Oncology/Hematology 2015; 96(2): 262 doi: 10.1016/j.critrevonc.2015.05.015
22
Pablo Letelier, Ismael Riquelme, Alfonso Hernández, Neftalí Guzmán, Jorge Farías, Juan Roa. Circulating MicroRNAs as Biomarkers in Biliary Tract CancersInternational Journal of Molecular Sciences 2016; 17(5): 791 doi: 10.3390/ijms17050791
23
Fang Bao, Jiayue Liu, Haiyang Chen, Lu Miao, Zhaochao Xu, Guixin Zhang. Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based StudyCancers 2022; 14(16): 3921 doi: 10.3390/cancers14163921